nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromopride—DRD2—Parkinson's disease	0.935	1	CbGaD
Bromopride—DRD2—Dopamine receptors—DRD1—Parkinson's disease	0.00473	0.0989	CbGpPWpGaD
Bromopride—DRD2—Dopamine receptors—DRD3—Parkinson's disease	0.00458	0.0958	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—PPP1R1B—Parkinson's disease	0.00352	0.0735	CbGpPWpGaD
Bromopride—DRD2—telencephalic ventricle—Parkinson's disease	0.00334	0.288	CbGeAlD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—DDC—Parkinson's disease	0.0024	0.0502	CbGpPWpGaD
Bromopride—DRD2—nerve—Parkinson's disease	0.0021	0.181	CbGeAlD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—SLC18A2—Parkinson's disease	0.00204	0.0427	CbGpPWpGaD
Bromopride—Chloroprocaine—SLC6A3—Parkinson's disease	0.00185	0.354	CrCbGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Parkinson's disease	0.00161	0.0338	CbGpPWpGaD
Bromopride—DRD2—hindbrain—Parkinson's disease	0.00158	0.136	CbGeAlD
Bromopride—Metoclopramide—DRD3—Parkinson's disease	0.00155	0.296	CrCbGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRM5—Parkinson's disease	0.0015	0.0314	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Parkinson's disease	0.00145	0.0304	CbGpPWpGaD
Bromopride—DRD2—Nicotine Activity on Dopaminergic Neurons—TH—Parkinson's disease	0.00134	0.028	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR1A—Parkinson's disease	0.00108	0.0226	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—DRD1—Parkinson's disease	0.00107	0.0224	CbGpPWpGaD
Bromopride—Metoclopramide—DRD2—Parkinson's disease	0.00107	0.205	CrCbGaD
Bromopride—DRD2—Monoamine GPCRs—DRD1—Parkinson's disease	0.00105	0.0219	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—DRD3—Parkinson's disease	0.00101	0.0212	CbGpPWpGaD
Bromopride—DRD2—Hypothetical Network for Drug Addiction—GRIN2B—Parkinson's disease	0.000969	0.0203	CbGpPWpGaD
Bromopride—DRD2—Monoamine GPCRs—HTR7—Parkinson's disease	0.000916	0.0191	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.00091	0.019	CbGpPWpGaD
Bromopride—DRD2—brainstem—Parkinson's disease	0.000903	0.0779	CbGeAlD
Bromopride—DRD2—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000879	0.0184	CbGpPWpGaD
Bromopride—DRD2—forebrain—Parkinson's disease	0.000871	0.0751	CbGeAlD
Bromopride—DRD2—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000851	0.0178	CbGpPWpGaD
Bromopride—DRD2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.00077	0.0161	CbGpPWpGaD
Bromopride—Metoclopramide—CYP2D6—Parkinson's disease	0.000756	0.145	CrCbGaD
Bromopride—DRD2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000641	0.0134	CbGpPWpGaD
Bromopride—DRD2—midbrain—Parkinson's disease	0.000575	0.0496	CbGeAlD
Bromopride—DRD2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000539	0.0113	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000517	0.0108	CbGpPWpGaD
Bromopride—DRD2—head—Parkinson's disease	0.000499	0.043	CbGeAlD
Bromopride—DRD2—nervous system—Parkinson's disease	0.000473	0.0408	CbGeAlD
Bromopride—DRD2—central nervous system—Parkinson's disease	0.000455	0.0393	CbGeAlD
Bromopride—DRD2—cerebellum—Parkinson's disease	0.000445	0.0384	CbGeAlD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000443	0.00926	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—DDC—Parkinson's disease	0.000394	0.00823	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000379	0.00791	CbGpPWpGaD
Bromopride—DRD2—brain—Parkinson's disease	0.000362	0.0312	CbGeAlD
Bromopride—DRD2—G alpha (i) signalling events—PENK—Parkinson's disease	0.000359	0.0075	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—GPR37—Parkinson's disease	0.000337	0.00705	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000328	0.00686	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000294	0.00615	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000285	0.00597	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000261	0.00546	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—DRD1—Parkinson's disease	0.000246	0.00515	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000241	0.00503	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—DRD3—Parkinson's disease	0.000239	0.00499	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—GRM4—Parkinson's disease	0.000229	0.00479	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000225	0.00471	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—TH—Parkinson's disease	0.00022	0.00459	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—PENK—Parkinson's disease	0.000217	0.00454	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—HTR7—Parkinson's disease	0.000216	0.00451	CbGpPWpGaD
Bromopride—DRD2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000211	0.0044	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000209	0.00437	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000206	0.00431	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000202	0.00422	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—PDYN—Parkinson's disease	0.000199	0.00415	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000195	0.00409	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000191	0.00398	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—GRM5—Parkinson's disease	0.000185	0.00386	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000179	0.00374	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000177	0.00369	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000176	0.00369	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—GPR37—Parkinson's disease	0.000173	0.00362	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000173	0.00362	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000173	0.00361	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000167	0.0035	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000158	0.00331	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000157	0.00328	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000151	0.00317	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000144	0.00302	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000136	0.00285	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	0.000134	0.00281	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	0.000132	0.00275	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	0.000131	0.00274	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00013	0.00271	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	0.000128	0.00267	CbGpPWpGaD
Bromopride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000124	0.00259	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—VPS35—Parkinson's disease	0.000123	0.00258	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	0.000123	0.00257	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000121	0.00253	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	0.000118	0.00246	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	0.000115	0.00241	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000112	0.00235	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PENK—Parkinson's disease	0.000112	0.00233	CbGpPWpGaD
Bromopride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000106	0.00222	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000104	0.00218	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	0.000102	0.00214	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GPR37—Parkinson's disease	0.000102	0.00214	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	0.000102	0.00213	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	9.48e-05	0.00198	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	9.35e-05	0.00195	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	9.23e-05	0.00193	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.88e-05	0.00186	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	8.21e-05	0.00172	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—RIT2—Parkinson's disease	8.17e-05	0.00171	CbGpPWpGaD
Bromopride—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	8.08e-05	0.00169	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	8.06e-05	0.00169	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GRK5—Parkinson's disease	7.75e-05	0.00162	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	7.7e-05	0.00161	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	7.59e-05	0.00159	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	7.44e-05	0.00156	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	7.21e-05	0.00151	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	7e-05	0.00146	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GRM4—Parkinson's disease	6.95e-05	0.00145	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	6.89e-05	0.00144	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	6.76e-05	0.00141	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.73e-05	0.00141	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PENK—Parkinson's disease	6.59e-05	0.00138	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—MAG—Parkinson's disease	6.59e-05	0.00138	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	6.54e-05	0.00137	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	6.52e-05	0.00136	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	6.11e-05	0.00128	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—PDYN—Parkinson's disease	6.03e-05	0.00126	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	5.92e-05	0.00124	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GFAP—Parkinson's disease	5.66e-05	0.00118	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—GRM5—Parkinson's disease	5.6e-05	0.00117	CbGpPWpGaD
Bromopride—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	5.25e-05	0.0011	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	5.22e-05	0.00109	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—FGF20—Parkinson's disease	4.91e-05	0.00103	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	4.76e-05	0.000996	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	4.74e-05	0.00099	CbGpPWpGaD
Bromopride—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.56e-05	0.000954	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—INSR—Parkinson's disease	4.4e-05	0.000919	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—FGB—Parkinson's disease	4.15e-05	0.000868	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	4.14e-05	0.000866	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	4.13e-05	0.000864	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—TAC1—Parkinson's disease	4.07e-05	0.000851	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DRD1—Parkinson's disease	3.99e-05	0.000834	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—DRD3—Parkinson's disease	3.87e-05	0.000808	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	3.61e-05	0.000755	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR7—Parkinson's disease	3.5e-05	0.000731	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—IGF2—Parkinson's disease	2.93e-05	0.000612	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	2.83e-05	0.000592	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—EDN1—Parkinson's disease	2.8e-05	0.000585	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—NGF—Parkinson's disease	2.57e-05	0.000538	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	2.45e-05	0.000512	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—APOE—Parkinson's disease	2.28e-05	0.000476	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—INS—Parkinson's disease	1.94e-05	0.000407	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—CASP3—Parkinson's disease	1.45e-05	0.000303	CbGpPWpGaD
Bromopride—DRD2—Signaling by GPCR—IL6—Parkinson's disease	1.44e-05	0.000301	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.33e-05	0.000278	CbGpPWpGaD
Bromopride—DRD2—Signaling Pathways—IL6—Parkinson's disease	8.5e-06	0.000178	CbGpPWpGaD
